Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Questions Answered on ART Safety and Tolerability in Aging Patients and Populations With Cardiometabolic Toxicities

Source: State of the ART: Applying Up-to-Date Safety and Tolerability Data to Individualize HIV Care
Hear from expert faculty as they answer questions and discuss key considerations when evaluating potential ARV-related toxicities in special populations, including aging patients and populations with cardiometabolic toxicities.
Marta Boffito, MD, PhD, FRCP
Jens D. Lundgren, MD, DMSc
Released: January 17, 2023

In this episode, Marta Boffito, MD, PhD, FRCP, and Jens D. Lundgren, MD, DMSc, address key considerations when evaluating antiretroviral therapy safety and tolerability in aging patients and those with possible cardiometabolic toxicities, including:

  • Monitoring for cardiometabolic syndromes (eg, lipid panels, coronary artery calcification scores) 
  • Approaching antiretroviral-related weight gain in clinical practice 
  • Interpreting results from RESPOND on cardiovascular risk with integrase strand transfer inhibitors
  • Collaborating with other specialties (eg, cardiologists, dietitians) to provide a multidisciplinary approach for managing comorbidities, including prevention and management

Information on this Educational Activity

Faculty

Marta Boffito, MD, PhD, FRCP

Consultant Physician/Professor
HIV/Research
Chelsea and Westminster Hospital
Imperial College London
London, United Kingdom

Marta Boffito, MD, PhD, FRCP: consultant/advisor/speaker: Cipla, Gilead Sciences, GlaxoSmithKline, Janssen, Merck Sharp and Dohme, ViiV Healthcare; researcher: Novavax, Roche, Valneva.
Jens D. Lundgren, MD, DMSc

Professor
Rigshospital, University of Copenhagen
Director
Centre of Excellence for Health, Immunity and Infection (CHIP)
Rigshospital, University of Copenhagen
Copenhagen, Denmark

Jens D. Lundgren, MD, DMSc, has no relevant financial relationships to disclose.

Program Medium

This program has been made available online.

Acknowledgements

Provided by Clinical Care Options, LLC
Contact Info

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Janssen Therapeutics, Division of Janssen Products, LP
ViiV Healthcare

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings